On June 13, 2022, Mike Webb and Bevin O'Neil were appointed to the board of directors (the “Board”) of Enveric Biosciences, Inc. (the “Company”), to serve as directors of the Board for terms expiring at the 2022 annual meeting of the Company's stockholders, or until either of Mr. Webb or Ms. O'Neil's successor is duly elected and qualified, or his or her earlier death, resignation or removal. The Board has appointed Ms. O'Neil to serve on the Audit Committee of the Board and appointed Mr. Webb to serve on the Science and Technology Committee of the Board. There are no arrangements or understandings between either Mr. Webb or Ms. O'Neil and any other persons pursuant to which Mr. Webb or Ms. O'Neil were selected to serve as directors the Company.

In addition, there are no transactions between the Company and either Mr. Webb or Ms. O'Neil or his or her immediate family members requiring disclosure under Item 404(a) of Regulation S-K promulgated under the Securities Act of 1933, as amended.